Dynamic Predictions and Prospective Accuracy in Joint Models for Longitudinal and Time‐to‐Event Data

In longitudinal studies it is often of interest to investigate how a marker that is repeatedly measured in time is associated with a time to an event of interest. This type of research question has given rise to a rapidly developing field of biostatistics research that deals with the joint modeling of longitudinal and time-to-event data. In this article, we consider this modeling framework and focus particularly on the assessment of the predictive ability of the longitudinal marker for the time-to-event outcome. In particular, we start by presenting how survival probabilities can be estimated for future subjects based on their available longitudinal measurements and a fitted joint model. Following we derive accuracy measures under the joint modeling framework and assess how well the marker is capable of discriminating between subjects who experience the event within a medically meaningful time frame from subjects who do not. We illustrate our proposals on a real data set on human immunodeficiency virus infected patients for which we are interested in predicting the time-to-death using their longitudinal CD4 cell count measurements.

[1]  Yingye Zheng,et al.  Prospective Accuracy for Longitudinal Markers , 2007, Biometrics.

[2]  B P Carlin,et al.  Response of CD4 lymphocytes and clinical consequences of treatment using ddI or ddC in patients with advanced HIV infection. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[3]  Elia Biganzoli,et al.  A time‐dependent discrimination index for survival data , 2005, Statistics in medicine.

[4]  M. Wulfsohn,et al.  A joint model for survival and longitudinal data measured with error. , 1997, Biometrics.

[5]  Dimitris Rizopoulos,et al.  JM: An R package for the joint modelling of longitudinal and time-to-event data , 2010 .

[6]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[7]  R Henderson,et al.  Joint modelling of longitudinal measurements and event time data. , 2000, Biostatistics.

[8]  Cécile Proust-Lima,et al.  Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach. , 2009, Biostatistics.

[9]  Geert Verbeke,et al.  Fully exponential Laplace approximations for the joint modelling of survival and longitudinal data , 2009 .

[10]  F. Hsieh,et al.  Joint modelling of accelerated failure time and longitudinal data , 2005 .

[11]  Menggang Yu,et al.  Individual Prediction in Prostate Cancer Studies Using a Joint Longitudinal Survival–Cure Model , 2008 .

[12]  Xihong Lin,et al.  A penalized likelihood approach to joint modeling of longitudinal measurements and time-to-event data , 2008 .

[13]  Geert Molenberghs,et al.  Shared parameter models under random effects misspecification , 2008 .

[14]  Ning Li,et al.  A Joint Model for Longitudinal Measurements and Survival Data in the Presence of Multiple Failure Types , 2008, Biometrics.

[15]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[16]  P. Heagerty,et al.  Survival Model Predictive Accuracy and ROC Curves , 2005, Biometrics.

[17]  M. Schemper,et al.  Predictive Accuracy and Explained Variation in Cox Regression , 2000, Biometrics.

[18]  Menggang Yu,et al.  Individualized Predictions of Disease Progression Following Radiation Therapy for Prostate Cancer , 2005 .

[19]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical , 2002 .

[20]  Menggang Yu,et al.  JOINT LONGITUDINAL-SURVIVAL-CURE MODELS AND THEIR APPLICATION TO PROSTATE CANCER , 2004 .

[21]  F. Harrell,et al.  Evaluating the yield of medical tests. , 1982, JAMA.

[22]  Aeilko H. Zwinderman,et al.  A joint latent class changepoint model to improve the prediction of time to graft failure , 2007 .

[23]  Jane-Ling Wang,et al.  Modeling Longitudinal Data with Nonparametric Multiplicative Random Effects Jointly with Survival Data , 2008, Biometrics.

[24]  J. Ibrahim,et al.  A Flexible B‐Spline Model for Multiple Longitudinal Biomarkers and Survival , 2005, Biometrics.

[25]  J. Neaton,et al.  A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS. , 1994, The New England journal of medicine.

[26]  D. Thomas,et al.  Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach. , 1996, Statistics in medicine.

[27]  Marie Davidian,et al.  A Semiparametric Likelihood Approach to Joint Modeling of Longitudinal and Time‐to‐Event Data , 2002, Biometrics.